This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,788.48 firm fixed-price delivery order is for the supply of 40 mg capsules of the drug Aprepitant. The contract has an ultimate completion date of November 20, 2024.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies.
The contract award reviewed was not designated with any set-aside requirements, indicating open competition. No subcontractor information was provided.
Generated 2/18/25, 1:47 PM